Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）
Recruiting · NCT06500312 · Observational (researchers observe without assigning treatment) · Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
View the official record on ClinicalTrials.gov →What this trial is about
This is the prospective, observational cohort study (Radiogenomics-Lung), which aims to explore the relationship between the imaging information of lung cancer patients, tumor microenvironment and the prognosis of lung cancer patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients were treated for lung cancer in Wuhan Union Hospital from July 2024 to July 2027;
- Aged \> 18 years old;
- At least one chest CT scan before treatment;
- Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignancy other than lung cancer;
- Unclear pathological diagnosis。
Where it is running
1 location listed.
- Union Hospital，Tongji Medical College，Huazhong University of Science and Technology - Wuhan, Hubei, China